Investor

Also: Hospital and health system software maker Olive closes $106 million; Ready's tech-enabled on-demand home care locks up $54 million.

Some femtech companies struggle to get their ads approved on social media platforms due to prohibited-content rules and confusion of the rules. 

Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders.

Initially, Amwell planned to sell 35 million shares between $14 and $16 with up to 5.2 million additional shares for underwriters. 

Activist short seller Citron Research called the Israeli digital X-ray company out on its limited R&D expenditure, suspicious distribution agreements and other factors. Nanox has described the report as incorrect and misleading.

The company offers virtual care visits, virtual outpatient pathways and a tech platform for doctors to conduct virtual visits. 

The company has raised a lifetime total of $50 million.

With these funds, the telehealth company said it will be expanding platform and launching new supporting products and services.

The companies will be collaborating on a prescription digital therapeutic for patients with schizophrenia built on Click Therapeutics' tech platform.

Plus: Amazon says Halo to the wearable space.